Impact of medication correction of labor weakness on obstetrical complications and newborn status




oxytocin, weakness of labor, fetal, distress, cesarean section


Objectives: To analyze the impact of medical correction of labor weakness with oxytocin on obstetric and newborn complications.
Materials and methods. 100 cases of childbirth with weakness of labor activity and medical correction with oxytocin (main group) and 50 cases of childbirth without weakness of labor activity (control group) were analyzed. The analysis included pregnancy and childbirth histories of mothers aged 20–32 years with a gestation period of 37– 41 weeks with uncomplicated pregnancies, without significant somatic and obstetric-gynecological pathology, who gave birth in the Perinatal Center of Kyiv during the last 3 years.
Depending on the method of delivery, the women of the main group were divided into 3 subgroups: Iа – natural vaginal, spontaneous delivery (n = 60),
Ib – operative vaginal delivery using a vacuum extractor (n = 22), Іc – delivery by cesarean section (n = 18).
The following factors were studied in each group: assessment of newborns status according to the Apgar scale at the 1st and 5th minutes, pH level of the umbilical cord blood, frequency of fetal distress based on cardiotocography (Fischer score < 6 points), duration of labor induction, color of the amniotic fluid.
Results. The average duration of labor was the largest in the subgroup of spontaneous vaginal deliveries, the smallest in the subgroup of cesarean section. In subgroup Ib in 14 (63.6%) cases indications for the vacuum extractor were signs of fetal distress and only in 8 (36.4%) cases – weakness of labor activity.
In subgroup Ia compared to subgroup Ic, there was a longer average duration of labor and higher percentage of deliveries with meconium-stained waters (28.3%), higher frequency of neonatal acidemia (16.7%) and the birth of children with an Apgar score at the 5th minute ≤ 6 points (8.4%). In subgroup Ic compared to subgroup Ia, there was a higher value of cases of Fischer score < 6 points (50%), the duration of labor reinforcement for more than 4 hours (44.5%), more cases of asphyxia (44.5%), and the birth of children with an Apgar score at the 1st minute ≤ 6 points (38.9%). Indications for caesarean section in subgroup Ic in 50% of cases were signs of fetal distress, in 38.9% – weakness of labor activity which was not associated with medication, in 11.1% – a clinically narrow pelvis.
In all groups there was a relationship between the duration of labor induction and the condition of the newborn (the frequency of asphyxia of newborns was higher when the infusion of oxytocin lasted more than 4 hours).
In subgroup Ib fetal distress was the indication for urgent delivery in 63.6% of cases, and in subgroup Iс it was 50%. This indicates signs of a mediated negative effect of exogenous oxytocin on the fetus during childbirth. The newborns condition, according to the studied criteria, was worse in the groups with labor reinforcement compared to the control group, regardless of the method of delivery.
Conclusions. The use of oxytocin during childbirth can have a negative effect on the fetus, which increases the frequency of operative vaginal deliveries and cesarean sections and, as a result, is a risk factor for complications in the postpartum period. There is a correlation between duration of oxytocin injection and condition of the newborn.

Author Biographies

V.V. Bila, Kyiv City Perinatal Center, Kyiv

PhD, director

V.O. Golianovskyi, Kyiv City Perinatal Center, Kyiv

PhD, head of the Delivery Department

A.V. Makarova, Kyiv City Perinatal Center, Kyiv



  1. Zhang, L., Troendle, J., Branch, D.W., et al. “The expected labor progression after labor augmentation with oxytocin: A retrospective cohort study.” PLoS One 13.10 (2018): e0205735. DOI: 10.1371/journal.pone.0205735
  2. National Institute for Health and Care Excellence. NICE Clinical guideline [CG190] Intrapartum care for healthy women and babies. Available from: [], last updated: 14 Dec 2022.
  3. American Congress of Obstetricians and Gynecologists. ACOG guideline “Approaches to Limit Intervention During Labor and Birth”. Number 766 (Replaces Committee Opinion No. 687, February 2017. Reaffirmed 2021). Available from: [].
  4. Robert, M.E., Satin, A.J. “Labor: Overview of normal and abnormal progression.” UpToDate. May 02, 2022.
  5. Satin, A.J. “Labor: Diagnosis and management of the latent phase.” UpToDate. May 10, 2022
  6. Tilden, E.L., Phillippi, J.C., Ahlberg, M., et al. “Describing latent phase duration and associated characteristics among 1281 low-risk women in spontaneous labor.” Birth 46 (2019): 592.
  7. Zhang, J., Branch, D.W., Ramirez, M.M., et al. “Oxytocin regimen for labor augmentation, labor progression, and perinatal outcomes.” Obstet Gynecol 118.2 (2011): 249–56.
  8. Reinl, E.L., Goodwin, Z.A., Raghuraman, N., et al. “Novel oxytocin receptor variants in laboring women requiring high doses of oxytocin.” Am J Obstet Gynecol 217.2 (2017): 214.e1–214.e8.
  9. McAdow, M., Xu, X., Lipkind, H., et al. “Association of Oxytocin Rest During Labor Induction of Nulliparous Women With Mode of Delivery.” Obstet Gynecol 135.3 (2020): 569–75.
  10. Wright, A., Nassar, A.H., Visser, G., et al. “FIGO Good Clinical Practice Paper: Management of the second stage of labor.” Int J Gynaecol Obstet 152.2 (2021): 172–81. DOI: 10.1002/ijgo.13552
  11. Boie, S., Glavind, J., Uldbjerg, N., et al. “Continued versus discontinued oxytocin stimulation in the active phase of labour (CONDISOX): double blind randomised controlled trial.” BMJ 373 (2021). DOI: 10.1136/bmj.n716 (Published 14 April 2021).
  12. Baskett, T.F., Calder, A.A., Arulkumaran, S. Munro Kerr’s Operative Obstetrics, 11th Edition, Elsevier Ltd (2015): 55–71.
  13. Frey, H.A., Tuuli, M.G., England, S.K., et al. “Factors associated with higher oxytocin requirements in labor.” J Matern Neonatal Med 28.13 (2015): 1614–9.
  14. Balki, M., Erik-Soussi, M., Kingdom, J., Carvalho, J.C.A. “Oxytocin pretreatment attenuates oxytocin-induced contractions in human myometrium in vitro.” Anesthesiology 119.3 (2013): 552–61. DOI: 10.1097/ ALN.0b013e318297d347
  15. Uvnäs-Moberg, K., Ekström-Bergström, A., Berg, M., et al. “Maternal plasma levels of oxytocin during physiological childbirth – a systematic review with implications for uterine contractions and central actions of oxytocin.” BMC Pregnancy Childbirth 19.1 (2019): 285. DOI: 10.1186/s12884-019-2365-9
  16. Derbel, M., Mekki, D., Riahi, A., et al. “Comparison of two oxytocin administration protocols in elective cesarean section: 5 iu versus 10 iu.” Tunis Med 94.4 (2016): 253–8.
  17. Holleboom, C.G., van Eyck, J., Koenen, S.V., et al. “Carbetocin in comparison with oxytocin in several dosing regimens for the prevention of uterine atony after elective caesarean section in the Netherlands.” Arch Gynecol Obstet 287.6 (2013): 1111–7. DOI: 10.1007/s00404-012- 2693-8
  18. Somjit, M., Surojananon, J., Kongwattanakul, K., et al.“Comparison of Low Dose versus High Dose of Oxytocin for Initiating Uterine Contraction During Cesarean Delivery: A Randomized, Controlled, Non-Inferiority Trial.” Int J Womens Health (2020): 12: 667–73.
  19. Likhachov, V.K. Modern obstetric practice [Obstetrics. Volume 2]. Vinnytsya (2022): 340–70.
  20. Carlson, N.S., Corwin, E.J., Lowe, N.K. “Oxytocin Augmentation in Spontaneously Laboring, Nulliparous Women: Multilevel Assessment of Maternal BMI and Oxytocin Dose.” Biol Res Nurs 19.4 (2017): 382–92. PMID: 28347147.
  21. Garabedian, M.J., Hansen, W.F., McCord, L.A., et al. “Up-regulation of oxytocin receptor expression at term is related to maternal body mass index.” Am J Perinatol 30.6 (2013): 491–7.
  22. Qian, Х., Li, P., Shi, S.Q., et al. “Simultaneous recording and analysis of uterine and abdominal muscle electromyographic activity in nulliparous women during labor.” Reprod Sci 24.3 (2017): 471–7.
  23. Qian, X., Wang, Q., Ou, X., et al. “Effects of Ropivacaine in Patient-Controlled Epidural Analgesia on Uterine Electromyographic Activities during Labor.” Biomed Res Int 2018 (2018): 7162865. DOI: 10.1155/2018/7162865
  24. Brennan, D.J., McGee, S.F., Rexhepaj, E., et al. “Identification of a myometrial molecular profile for dystocic labor.” BMC Pregnancy and Childbirth 11 (2011): 74. DOI: 10.1186/1471-2393-11-74
  25. Al-Qahtani, S., Heath, A., Quenby, S., et al. “Diabetes is associated with impairment of uterine contractility and high Caesarean section rate.” Diabetologia 55.2 (2012): 489–98. DOI: 10.1007/s00125-011-2371-6
  26. Son, M., Roy, A., Grobman, W.A., et al. “Maximum Dose Rate of Intrapartum Oxytocin Infusion and Associated Obstetric and Perinatal Outcomes.” Obstet Gynecol 141.2 (2023): 379–86. DOI: 10.1097/AOG.0000000000005058



How to Cite

Bila, V., Golianovskyi, V., & Makarova, A. (2023). Impact of medication correction of labor weakness on obstetrical complications and newborn status. REPRODUCTIVE ENDOCRINOLOGY, (67), 84–89.



Pregnancy and childbirth